Topic
Tyrosine Kinase Inhibitor (TKI)
5 Podcasts • 1 Course on BackTable
Episode # 59 • 12 May 2026
Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most likely to shape HCC care? In this final episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi focus on the future of hepatocellular carcinoma beyond established PD-1/CTLA-4 regimens.
More on Tyrosine Kinase Inhibitor (TKI)
Loading recent podcasts…
Tumor Board Episode #59
May 12, 2026
with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart
With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...
150+ listens
Tumor Board Episode #57
Apr 28, 2026
with Dr. Lingling Du, Dr. Craig Lockhart, Dr. Jonathan Mizrahi
Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In...
170+ listens
Tumor Board Episode #3
Jan 17, 2025
with Dr. Lingling Du, Dr. Jonathan Mizrahi, Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Tyler Sandow
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative...
2,100+ listens
Tumor Board Episode #58
May 5, 2026
with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
150+ listens
VI Episode #513
Jan 31, 2025
with Dr. Lingling Du, Dr. Jonathan Mizrahi, Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Tyler Sandow
In the past five years, the use of immunotherapeutic agents for advanced cancers has emerged as a promising alternative...
1,700+ listens
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.